Antibodies News and Research

RSS

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

Scientists evaluate the humoral and cellular immune responses in individuals who have received a third booster dose of mRNA-based COVID-19 vaccine.

17 Mar 2022

Two clever human antibodies can target Ebola and Sudan virus

Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers studied the immune responses in Syrian hamsters re-infected with SARS-CoV-2 Delta and B.1 variants three months after the primary infection.

17 Mar 2022

Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

Researchers quantified the humoral immune response against the mRNA-1273 COVID-19 vaccine using commercially available high throughput assays.

17 Mar 2022

MHRA authorizes new medicine for COVID-19 prevention

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the UK regulatory standards of safety, quality and effectiveness.

17 Mar 2022

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Researchers used a novel mathematical model to simulate SARS-CoV-2 dynamics inside the host.

17 Mar 2022

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.

17 Mar 2022

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

A recent study assessed the reduction in antibody titers observed after the third dose of SARS-CoV-2 BNT162b2 vaccine in adults.

17 Mar 2022

Frail and older males more vulnerable to COVID-19 than females

Researchers evaluated the association of biological sex, frailty, and age with the vaccine-elicited immunity against SARS-CoV-2.

17 Mar 2022

Study explores profiles of COVID-19 vaccines across different countries

A new study analyzed the amplitude, time, and adverse events associated with COVID-19 vaccines across different countries.

17 Mar 2022

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.

From nanoComposix 17 Mar 2022

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Researchers examine the safety and efficacy of mAbs in pregnant and postpartum women with COVID-19.

16 Mar 2022

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

An inhalable 'aerogel' loaded with DNA that encodes for the SARS-CoV-2 spike protein successfully induces an immune response against COVID-19 in the lungs of mice, according to new research conducted at Penn State.

16 Mar 2022

Yale researchers uncover how to control the blood-brain barrier with a molecule

The brain is composed of billions of neurons-; vulnerable cells that require a protective environment to function properly.

16 Mar 2022

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Researchers evaluated COVID-19 monoclonal antibody treatment in pregnant and postpartum women.

16 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

Convalescent antibodies do not enhance SARS-CoV-2 infection

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

16 Mar 2022

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Since the very beginning of the pandemic, there has been concern about the emergence of Guillain-Barré syndrome, a rare disorder where the body's immune system damages nerves. In some cases, nerve damage causes muscle weakness and paralysis.

16 Mar 2022

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Adequate glycemic control during the year after being vaccinated against the SARS-CoV-2 improves the relative immunological response.

15 Mar 2022

Antibodies News and Research

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

Two clever human antibodies can target Ebola and Sudan virus

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

MHRA authorizes new medicine for COVID-19 prevention

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

Frail and older males more vulnerable to COVID-19 than females

Study explores profiles of COVID-19 vaccines across different countries

Lateral flow assays: The possibilities beyond COVID-19

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

Yale researchers uncover how to control the blood-brain barrier with a molecule

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Convalescent antibodies do not enhance SARS-CoV-2 infection

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

How to make hybridoma-based antibody discovery more efficient eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News